PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | +2.7% | 24,944 | +4.1% | 0.00% | – |
| Q2 2023 | $150 | +32.7% | 23,961 | +1.5% | 0.00% | – |
| Q1 2023 | $113 | -29.4% | 23,617 | +28.8% | 0.00% | – |
| Q4 2022 | $160 | -99.9% | 18,339 | +2.7% | 0.00% | – |
| Q3 2022 | $213,000 | -4.1% | 17,864 | +14.4% | 0.00% | – |
| Q2 2022 | $222,000 | -26.5% | 15,613 | +7.6% | 0.00% | – |
| Q1 2022 | $302,000 | -74.5% | 14,504 | -71.7% | 0.00% | – |
| Q4 2021 | $1,183,000 | -73.8% | 51,224 | -66.3% | 0.00% | – |
| Q3 2021 | $4,523,000 | +15.2% | 151,778 | +27.1% | 0.00% | – |
| Q1 2021 | $3,926,000 | – | 119,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |